Brooklyn, New York, USA, 2021-June-29 — /Meridian Market Consultants/ — The report is titled ‘Nuclear Medicine Market Size, Shares, Insights and Forecast Report – 2028’. An overview of conceptual frameworks, analytical approaches of the Nuclear Medicine market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The Nuclear Medicine market is expected to grow at a significant rate in the near future.

The global Nuclear Medicine market was valued US$ 34.1 Bn at the end of 2020 and expected to reach at a value of US$ 53.1 Bn by 2028 with a significant CAGR of 5.7%.




Get PDF Sample Copy of the Report including Full TOC, List of Tables & Figures, Chart: https://meridianmarketconsultants.com/sample-request/1146




Nuclear Medicine Market Dynamics

Evolution towards centralized pharmacies, widespread availability of the SPECT and PET scanning machines, the growing interest of investors of conventional pharmaceutical industries in the therapeutic area, increasing incidence of cancer and cardiovascular diseases are some of the factors that will drive the growth of the nuclear medicine market during the forecast period.

There has been a growing interest in the development of tracers for therapeutic indications during recent years. The increasing number of manufacturers and research organizations are focusing on introducing novel therapeutic radiopharmaceuticals in the market. For instance, in March 2016, Isotopen Technologien München (ITM) raised US$ 20.8 million to fund the clinical development of its promising proprietary pipeline of Targeted Radionuclide Therapies. Also, in May 2016, Clarity Pharmaceuticals, an early stage Australian company, was granted US$ 0.7 million by Federal Government’s in order to fast track the Phase IIa clinical trial of Cu-64 SARTATE, a neuroendocrine tumor imaging radiopharmaceutical.

 Ask for Customization: https://meridianmarketconsultants.com/free-customization/1146

Nuclear Medicine Market Key Players

Global nuclear medicine market is mainly dominated by:

Siemens AG
Eckert & Ziegler
Lantheus Holdings, Inc.
Cardinal Health
Bayer AG
Bracco Imaging S.P.A.
Nordian Inc.
Advanced Accelerator Applications
Mallinckrodt plc.

In 2017, the Siemens AG is accounted as the most dominating player in the global nuclear medicine market by holding more than 40% of the global nuclear medicine market followed by GE healthcare and Mallinckrodt PLC

Nuclear Medicine Market Segmentation

The global nuclear medicine market is segmented on the basis of application, radioisotope, source, end user, and by region.

On the basis of application segment, the global nuclear medicine market is segmented into:

Oncology
Cardiology
Gastroenterology
Neuroendocrinology
Neurology
Nephrology
Others

In 2018, the oncology application segment is accounted to have the largest market share in terms of value and expected to remain to dominate throughout the forecast period (2019-2027).




To Identify the Key Trends in the Global Industry, Visit: https://meridianmarketconsultants.com/global-Nuclear Medicine-market

About Meridian Market Consultants:

Meridian Market Consultants (MMC) is committed to providing deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Meridian Market Consultants (MMC)

1820 Avenue M,

Brooklyn, NY 11230

United States

Tel: +1-(281)-619-8646

Effects due to the COVID-19 Pandemic on Global Markets: Meridian Market Consultants | COVID-19 PANDEMIC & MARKET







Nuclear Medicine, Nuclear Medicine CAGR, US Nuclear Medicine share, UK Nuclear Medicine Size, MEA Nuclear Medicine Demand